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Abstract
Background
The rapid scale-up of HIV therapy across Africa has failed to adequately engage adoles-
cents living with HIV (ALWHIV). Retention and viral suppression for this group (ALWHIV) is
50% lower than for adults. Indeed, on the African continent, HIV remains the single leading
cause of mortality among adolescents. Strategies tailored to the unqiue developmental and
social vulnerabilities of this group are urgently needed to enhance successful treatment.
Methods
We carried out a five-year longitudinal cluster randomized trial (ClinicalTrials.gov ID:
NCT01790373) with adolescents living with HIV (ALWHIV) ages 10 to 16 years clustered at
health care clinics to test the effect of a family economic empowerment (EE) intervention on
viral suppression in five districuts in Uganda. In total, 39 accredited health care clinics from
study districts with existing procedures tailored to adolescent adherence were eligible to par-
ticipate in the trial. We used data from 288 youth with detectable HIV viral loads (VL) at
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Data Availability Statement: Our study
participants are adolescents living with HIV
(ALWHIV) and highly stigmatized. Thus, we stated
in the consent form that only de-identified
individual-level data may be shared outside of the
research team and only upon completion of the
following conditions: A formal research question is
specified a priori; Names, affiliations, and roles of
any other individuals who will access the shared
baseline (158 –intervention group from 20 clinics, 130 –non-intervention group from 19 clin-
ics). The primary end point was undetectable plasma HIV RNA levels, defined as < 40 cop-
ies/ml. We used Kaplan-Meier (KM) analysis and Cox proportional hazard models to
estimate intervention effects.
Findings
The Kaplan-Meier (KM) analysis indicated that an incidence of undetectable VL (0.254) was
significantly higher in the intervention condition compared to 0.173 (in non-intervention arm)
translated into incidence rate ratio of 1.468 (CI: 1.064–2.038), p = 0.008. Cox regression
results showed that along with the family-based EE intervention (adj. HR = 1.446, CI:
1.073–1.949, p = 0.015), higher number of medications per day had significant positive
effects on the viral suppression (adj.HR = 1.852, CI: 1.275–2.690, p = 0.001).
Interpretation
A family economic empowerment intervention improved treatment success for ALWHIV in
Uganda. Analyses of cost effectiveness and scalability are needed to advance incorporation
of this intervention into routine practice in low and middle-income countries.
Introduction
The public health response to adolescents and young persons living with HIV (ALWHIV) in
Africa has fallen short, and strategies to engage this group through addressing their unique
developmental needs as well as social and structural barriers to care are urgently needed. Over
the last ten years, over 20 million persons in resource-limited settings have newly started life-
saving ART, but progress has been uneven [1]. Retention and viral suppression among
ALWHIV is 50% lower than for adults and while HIV related mortality has fallen by 50% since
2005, HIV remains the single biggest cuase of mortality in adolescents in Africa [2, 3]. Sub-
optimal HIV treatment programs for adolescent are, in part, due to the fact that ALWHIV face
unique and diverse barriers to retention. They do not control household finances, and there-
fore, depend on caregivers for access to care. Adolescence is a period of life when peer influ-
ence, and therefore risk-taking, stigma and social factors may be particularly powerful [4].
Navigating health systems designed for either younger children or older adults, in particular
when coordination with schools is poor, poses distinct challenges to engagement in care [5].
While adolescents face diverse barriers to care, poverty represents an underlying structural
factor that exacerbates, either directly or indirectly, many, if not all, of the barriers to engage-
ment in care. In low- and middle-income countries (LMICs), consistent care demands a signif-
icant portion of their household income for medication fees, transport to medical visits, and
opportunity costs of time lost from work [6]. In quantitative surveys, commonly cited reasons
for poor adherence to ART include financial instability, poverty [7] and food insecurity, [8]
limited access to medical resources [7], and costs of transportation [9,10]. Adolescents are par-
ticularly vulnerable to household poverty, yet adherence to treatment regimens requires a level
of economic stability that many poor youths in Africa do not have/experience [15,16]. In
short, impoverished children and youth have been found to experience greater challenges to
ART adherence compared to children who are more economically stable [9–16]. Yet, to date,
no adherence interventions have focused on the underlying economic drivers, which might
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help explain why results of adherence interventions with HIV positive adolescents and adults
living in poverty have had small to moderate effects at best [17,18].
A study by Tuller and colleagues in western Uganda found that provision of free ART with-
out addressing other financial barriers (including the cost of transportation to clinics to pick-
up monthly refills) does not sufficiently address the problem of treatment interruptions [9].
The cost of transportation relative to income can be substantial, and often competes with
other essential expenses. Individuals who missed medication doses cited problems finding
transportation money as a key reason for not being able to maintain their regimen, explaining
that they were unable to afford to travel to the clinic before their supply of medication ran out.
Even for those not yet on ART, anxiety over the cost of transportation caused them to question
whether they would be able to adhere to their medication regimens once they initiated treat-
ment [9]. As a result, HIV positive patients tend to sacrifice healthcare, including adherence to
treatment, and other basic needs, including food and school fees for children due to financial
constraints [15–18]. Despite the limited literature on economic empowerment (EE) and ado-
lescent adherence, existing research suggests that EE has the potential to significantly improve
adherence outcomes, particularly viral suppression [15,16, 19–23].
In order to address the gaps in research, this paper assessed the long-term impact of a fam-
ily-based EE intervention on viral suppression as an indicator of adherence and HIV control
for ALWHIV. We used viral suppression, dichotomized as< 40 copies/ml (Undetectable)
vs> 40 copies/ml (detectable), as a proxy measurement of ART adherence.
In this paper, we report outcomes of a five-year cluster randomized trial to test the effect of
household EE on ALWHIV aged 10–16 years in HIV affected communitiesin Uganda on adher-
ence to HIV therapy as measured by viral load suppression (VS), dichotomized as< 40 copies/ml
(Undetectable) vs> 40 copies/ml (detectable). The data was collected at five time-points (base-
line, 12-, 24-, 36-, and 48- month post-intervention initiation). Grounded in asset theory [24],
which posits that family EE and asset ownership have tremendous developmental, psychological
and social benefits for individuals and households, the study aimed to evaluate the impact of an
innovative family based EE intervention composed of incentivized matched financial savings
accounts and microenterprise promotion (hereafter, Suubi+Adherence Intervention), versus med-
ical and psychosocial Standard of Care (SOC). Both groups received enhanced information ses-
sions on ART adherence using print cartoons that convey adherence topics in a relatable manner.
Materials and methods
Study design
We approached health care facilities in Western Uganda and sought to enroll ALWHIV receiv-
ing care at those facilities into the study. Nine-hundred ninety (990) adolescents from 40 health
care clinics were identified and screened for eligibility to participate in the study (see Fig 1 for
Baseline Consort Flow Diagram). The eligibility criteria for the clinics included: 1) having exist-
ing procedures tailored to adolescent adherence (including adolescent clinic days and peer
counseling); and 2) being accredited by the Ugandan Ministry of Health as a provider of ART
within the five study districts: Rakai, Kyotera, Masaka, Lwengo and Kalungu. Based on those
inclusion criteria, one clinic was excluded, leaving a total of 39 clinics within the study sample.
The inclusion criteria for adolescents were: 1) 10–16 years at enrollment; 2) HIV-positive and
aware of status (previously tested for HIV and confirmed by a medical report); 3) prescribed
ART; 4) registered at one of the participating clinics/health centers for follow-up care and drug
refills; and 5) non-institutionalized (i.e. living within families and not institutions). Following
the screening, consent and assent processes, 702 study participants from the 39 clinics were
interviewed by trained staff at baseline. All the interviews were conducted in Luganda—the
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local language widely spoken in the study area. The remaining 288 adolescents were excluded
from study participation due to: a) lack of awareness of HIV status (i.e. not disclosed to by their
caregiving families); b) being under or over the study age; and c) in few instances, the inability
to comprehend study procedures as assessed during the screening process (Fig 1).
Over the course study, in total, 28 participants died from the disease and 18 participants
were lost at subsequent follow-up points (could not be located at subsequent follow-ups and
their VL tests could not be performed).
Ethical clearance
The study obtained IRB approval from Columbia University (Protocol AAAK3852), the
Makerere University School of Public Health (Protocol 210) and the Uganda National Council
for Science and Technology (Protocol SS 2969). The aims and objectives of the study were
Fig 1. CONSORT flow diagram.
https://doi.org/10.1371/journal.pone.0228370.g001
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explained to both caregivers who provided written consent for their children to participate in
the study and their children who provided assent. All research assistants completed certifica-
tions in Good Clinical Practices and CITI (Collaborative Institutional Training Initiative)
human subjects training. Using back-translation approach/method, all measures were trans-
lated into Luganda and back to English by a local expert and certified by Makerere University
Institute of Languages (https://llc.mak.ac.ug/departments/deal).
Randomization
We approached health care facilities in Western Uganda and sought to enroll ALWHIV receiv-
ing care at those facilities into the study. Following baseline interviews, 39 clinics were ran-
domly assigned to either the intervention condition (n = 20 clinics, n = 358 participants) or
the non-intervention condition (19 clinics, n = 344 participants). The randomization was
based on: the number of children served at the health care facility, location—either rural,
urban or semi-urban and the level of health facility in Uganda’s health system. For instance,
our study included health center III, IVs and hospitals. To balance our randomization, hospi-
tals were randomized separately from other categories. We used a two-arm, cluster randomiza-
tion design where all participants attending the same clinic were assigned to the same study
group. This method was intended to minimize contamination or cross-overs. Randomization
of clinics was done by an independent Columbia University Research Assistant.
The Suubi+Adherence intervention
All participants received medical SOC, as defined by the Uganda Ministry of Health Guide-
lines for pediatric and adolescent HIV care and treatment; and psychosocial SOC, consisting
of information leaflets on adherence and support delivered by lay counselors, including people
living with HIV, trained in ART adherence counseling, known as “expert clients”. Due to
inconsistency with which SOC is provided in the study region, the Suubi+Adherence study
bolstered the SOC in both the control (non-intervention) and the intervention groups with
eight information sessions on ART adherence using print cartoons to portray adherence topics
in a relatable manner, based on a South African intervention for ALWHIV named VUKA
[25]. The bolstered SOC involved eight one-hour group sessions facilitated by a trained
research assistant. Adolescents in the intervention group received the bolstered SOC
(described above) as well as a family-based EE intervention consisting of child development
accounts (incentivized savings accounts matched at a rate of 1:1) plus microenterprise work-
shops [26]. The incentivized matched savings and microenterprise were for medical expenses
and/or education-related expenses for those ALWHIV in school (including school lunches).
The microenterprise workshops included four one-hour group sessions intended to provide
financial management and microenterprise development training to children and their care-
givers. In addition, participants in the treatment condition received 12 group-based educa-
tional sessions covering a variety of issues including but not limited to setting goals, business
development, and avoiding risk. All components of the financial savings and microenterprise
workshops have been previously proven feasible to implement and acceptable to participants
[27].
Statistical analysis
Viral suppression as reflected in HIV VL was used as the primary outcome of this analysis. VL
testing was done by the Rakai Health Sciences Program at each of the study’s time points: base-
line/pre-intervention initiation (time 0), 12-months post intervention initiation (time 1),
24-months post intervention initiation (time 2), 36-months post intervention initiation (time
The effects of economic empowerment intervention on HIV viral suppression among adolescents
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3) and 48-months post intervention initiation (time 4). Plasma VL measurements were quanti-
fied in blood samples collected in EDTA tubes using Abbott Real Time HIV-1 RNA PCR, ver-
sion 5.00. VL was dichotomized between undetectable /suppression (VL< 40 copies/ml) and
detectable/failed viral suppression (VL� 40 copies/ml) levels. In accordance with Abbot Real
Time system’s sensivity, 40 copies/ml was the lowest detactable value, and thus the most uni-
form indicator of viral suppression [28]. This binary indicator of VL, therefore, has greater
clinical relevance since most health care practitioners aim for patients to achieve viral
suppression.
The goal of any ART adherence is to achieve viral suppression. Thus, for this particular
analysis, we used the data of 288 youth who had detectable VL (> = 40 copies/ml) during the
baseline testing to explore the impact of the intervention among this group of youth. The pri-
mary exposure variable was the family-based EE intervention. In addition, we controlled for
demographic factors such as age, sex, schooling status, family structure (orphanhood status,
primary caregiver, number of people in the household) and therapy-related factors, such as
number of medications (to control the effect of increased pill burden that could lead to
decreased adherence) and time since the participant knew his/her HIV status (as an earlier dis-
closure would be protective) [29, 30], in the models.
Kaplan-Meier analysis was used to determine the cumulative probability of the attainment
of undetectable/suppressed VL over the 12, 24, 36 and 48-months. We used the Cox propor-
tional hazard (CPH) model to determine the effect of the intervention on the first time partici-
pants had undetectable VL adjusting for participants’ demographic characteristics such as age,
sex, orphanhood status, primary caregiver, schooling status as well as the number of medica-
tions and the time since they knew their HIV status [29, 30]. The person-time of follow-up was
calculated as inter-wave duration between any two subsequent waves. In addition, we con-
ducted marginal models [31] with robust standard errors to adjust for clustering of observa-
tions at the clinic level. The CPH model generated the incidence rate ratio as a measure of
association with corresponding 95% confidence intervals for all estimates, with< 40 copies/ml
coded as the event.
Statistical Significance was determined a priori at the 5% level. All analyses were conducted
using STATA version 15.
Results
Participant demographics
As presented in Table 1, the majority of study respondents were females (55.21%) with an aver-
age age of 12 years. In addition, 26.4% of respondents were double orphans (both birth parents
passed) while 35% reported that both parents were still living (non-orphans). About 42%
reported a parent as the primary caregiver and 16.7% were not enrolled in school at baseline.
The average number of people in the household was 6 adults and 2 children under the age of
18. The average (mean) time since learning of positive HIV status was 4 (95% CI = 3.54–4.21)
years.
The attrition rate for these participants across all the 5 waves was 9.7% -22 participants died
from the disease, while 6 participants were lost to follow-ups (could not be found at subsequent
follow-ups and their VL tests could not be performed). These were not statistically different
across study arms (chi2(3) = 4.36, p = 0.23). These participants were censored in correspond-
ing inter-time durations and made 288 at risk at time 0, 271 at risk (17—censored) at time 1;
265 at risk (6-censored) at time 2; 265 at risk (0—censored) at time 3 and 260 at risk (5 –cen-
sored) at time 4.
The effects of economic empowerment intervention on HIV viral suppression among adolescents
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The Kaplan-Meier results indicate that the total person-years of follow-up were 768 (393 –
treatment group, 375 –non-treatment group), resulting in an overall incidence of undetectable
VL of 0.21 (165/768); significantly higher in the intervention condition. In total, 165 partici-
pants achieved VS (100 participants from intervention group and 65 participants in non-inter-
vention group) (Fig 2). The incident rate of 0.254 (in treatment group) compared to 0.173 (in
non-intervention arm) translated into incidence rate ratio of 1.468 (CI: 1.063–2.038),
p = 0.008.
The Cox proportional hazard models indicated significant effects of the intervention on
participants’ HIV VL detectability. The unadjusted model showed that participants in the
intervention group had a higher hazard of 1.445 for undetectable VL (CI: 1.057–1.976,
p = 0.021). The results remained significant even after controlling for youth demographics and
their treatment specifics. Specifically, the analysis showed that participants in the intervention
group had a larger adjusted hazard of undetectable VL (HR = 1.446, CI: 1.073–1.949,
p = 0.015). Accounting for sampling variability, the increase in hazard for the intervention
group could be as large as 95% or as small as 7% (CI 1.073–1.949). The analysis also points to
the fact that the adolescents who were taking two or three different types of ART medications,
had a higher hazard for undetectable HIV VL. For instance, in case of two different types of
ART medications–the adolescents had 85.2% higher hazard (HR = 1.852, CI: 1.275–2.689,
p = 0.001) and in case of three ART medications– 90% higher hazard (HR: 1.90, CI: 1.075–
3.362, p = 0.027). (Table 2).
Table 1. Baseline characteristics by study arms (n = 288).
Characteristics Non-intervention Group n(95% CI) Intervention Group n(95% CI) Total n(95% CI)
Overall 130 (45.14) 158(54.86) 288 (100)
Sex
Female 78 (60.00) 81 (51.27) 159 (55.21)
Male 52 (40.00) 77 (48.73) 129 (44.79)
Age (years) (CI)
Age-Mean (CI) 12.39 (12.04–12.74) 12.59(12.27–12.90) 12.5 (12.27–12.73)
Orpanhood status
Double-orphan 38 (29.23) 38 (24.05) 76 (26.39)
Single-orphan 53 (40.77) 58 (36.71) 109 (38.54)
Both parents alive 39 (30.00) 62 (39.24) 103 (35.07)
Primary Caregiver
Parent(s) 47 (36.15) 75 (47.47) 122 (42.36)
Grandparent(s)_ 42 (32.30) 44 (27.85) 86 (29.86)
Others 41 (31.54) 39 (24.68) 81 (27.78)
Current Schooling
Not in school 24 (18.46) 24 (15.19) 48 (16.67)
In school 106 (81.15) 134 (84.81) 240 (83.33)
Number of people in the household
Total (2–18) Mean (CI) 5.79 (5.34–6.25) 5.60 (5.21–6.00) 5.69 (5.39–5.99)
Children (0–14): Mean (CI) 2.35 (2.00–2.68) 2.21 (1.89–2.54) 2.27 (2.04–2.51)
Time since knew HIV status (years) (CI)
Mean (CI) 3.97 (3.46–4.48) 3.79(3.34–4.25) 3.87 (3.54–4.21)
Different types of ART medications
One 34 (26.15) 30 (18.99) 64 (22.22)
Two 73 (56.15) 90 (56.96) 163 (56.60)
Three 23 (17.69) 38 (24.05) 61 (21.18)
https://doi.org/10.1371/journal.pone.0228370.t001
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Additionally, statistical analyses were conducted to check for proportionality of the model
by including time-dependent covariates in the final model [32]. None of the time-dependent
variables were significant, either collectively or individually, thus, supporting the assumption
of proportional hazard. We checked the model fit using the Cox-Snell residuals and the Nel-
son-Aalen cumulative hazard function [33]. The hazard function was compared to the diago-
nal line and observed that hazard function followed the 45-degree line very closely except for
very large values of time. Overall, we concluded that the final model fits the data very well.
Assessing Schoenfeld residuals also supported the assumption that the model with covariates
had proportional-hazards [34].
Discussion
PLWHIV who adhere to ART treatment are able to live longer and healthier lives [35, 36].
Moreover, when virally suppressed, they are considerably less likely to transmit the virus [37,
38]. Poor or total non-adherence to ART treatment is often attributed to economic reasons,
specifically financial instability and poverty [7].
This study examined the impact of a family-based EE intervention on adherence to HIV
treatment for ALWHIV using undetectable HIV VL (<40 copies/ml) as a proxy indicator for
adherence. Analyses pointed to a significant intervention effect on VL suppression (Table 2)
among ALWHIV who had detectable VL at baseline. Results showed that following the initia-
tion of the intervention, the incidence of undetectable VL among participants in the interven-
tion group increased significantly compared to participants in the non-intervention group.
Fig 2. Kaplan-Meier survival estimates.
https://doi.org/10.1371/journal.pone.0228370.g002
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This finding supports work by Cluver and colleagues who point to the potential role of eco-
nomic interventions (e.g. cash transfers) in assisting with HIV care and retention [39].
These findings contribute to the ongoing discussion regarding the need for effective ART to
include VL monitoring (both as a health outcome and as a partial proxy measurement of
adherence) to ensure that the prescribed ART is working properly to suppress replication of
the virus and in case of necessity adjust the treatment accordingly [40, 41]. There is growing
concern that unchecked viremia leads to increased odds of HIV transmission, including drug
resistance [42]. Testing VL is considered the gold standard for HIV treatment monitoring [43,
44], however, it’s cost and complexity, among other issues, have presented major barriers to its
scale-up and use in LMICs [45, 46].
Overall, while our findings point to the potential of family based EE interventions in achiev-
ing VL suppression among ALWHIV, there is a need for more research to determine the
mechanisms through which the observed change happens For example, the VL suppression
could potentially be attributed to associated food security and the ability to access treatment in
a timely manner [47–49]. Alternatively, the fact that the intervention brings financial stability
to the home may result in increased medication-adherence because the ALWHIV feel more
hopeful [50]. Such factors need to be further examined both qualitatively and quantitatively.
Thus, research is needed to also explore mediators and moderators of the family-based EE
interventions on VL suppression.
Limitations
There are two main limitations of the study. First, the analyses only included data of youth
who had detectable VL at baseline and did not explore the impact of the treatment on those
Table 2. The results of the adjusted Cox proportional hazard model.
Undetectable viral load (<40 copies/ml) HR Ratio (95% CI) p
Intervention (ref: non-intervention group) 1.4457 1.0727 1.9486 0.0155
Different types of ART medications (ref: One)
Two 1.8521 1.2753 2.6896 0.0012
Three 1.9015 1.0754 3.3623 0.0271
Time since knew HIV status (years) 0.9874 0.9290 1.0495 0.6832
Sex (ref: male) 1.1519 0.9260 1.4328 0.2042
Age (years) 0.9407 0.8516 1.0390 0.2278
Current Schooling 1.2889 0.9379 1.7711 0.1177
Orpanhood status (ref: both parents are alive)
Single orphan 1.2089 0.8530 1.7132 0.2864
Double orphan 1.4857 0.2157 2.7808 0.2157
Primary Caregiver (ref: Parent(s))
Grandparent(s)_ 0.6954 0.4127 1.1718 0.1724
Others 0.8345 0.4868 1.4305 0.5106
Number of people in the household:
Adults 0.9914 0.8989 1.0934 0.8629
Children 1.0391 0.8964 1.2046 0.6105
Wald test chi2(13) = 53.50
Log pseudolikelihood -844.30401
Prob > chi2 <0.0001
Number of subjects 277
Number of failures 165
Time at risk / Number of Observations 767
https://doi.org/10.1371/journal.pone.0228370.t002
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who were undetectable at baseline, but may have become detectable, with possible VL blips
(fluctuation of VL throughout the course of the study). Also, as this paper focused on the
impact of the treatment only on the dichotomized outcome variable, dichotomized as unde-
tectable (<40 copies/ml) vs detectable (�40 copies/ml), further research is needed to explore
the impact of the treatment on continuous VLs or other cut points.
Second, even though testing VL is considered the gold standard for HIV treatment moni-
toring and an undetectable VL level is consistent with good medication adherence, detectable
levels are not necessarily universally diagnostic of non-adherence, given that other factors may
influence viremia, including treatment resistance [42]. In addition, biological markers only
provide data for one specific point and do not usually reflect variations in adherence over time
[51]. Viral suppression takes time and viremia may also take time to emerge. By the time some-
one is not virally suppressed, they most probably have been non-adherent for some time [52].
Thus, more regular assessments/check-ups for adherence using different direct and non-direct
methods are recommended.
Conclusions
The study findings indicated that family-based EE interventions can increase rates of VL sup-
pression, and thereby, improve the health of youth, minimize HIV transmission, and superin-
fections [53]. However, there is a need for more research on the impact of family-based EE
interventions on ART adherence in more detail. Specifically, Suubi+Adherence supported
children and families to gain financial literacy and strengthen their economic security.
Research should be continued to explore the effect of EE interventions on food insecurity, pov-
erty and financial constraints associated with HIV and ART adherence in general.
Clinical significance
Our findings suggest that a family-based EE intervention has the potential to improve viral
suppression, and thus, the health of vulnerable ALWHIV in low-resource environments.
These findings contribute to the discussion on ending the HIV/AIDS epidemic and ART
responses, and emphasize the need for further research and policy dialogue on the intersec-
tions of financial security and HIV prevention and treatment.
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